Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Neoplasms and CIT[original query] |
|---|
| Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer. BMC medical genomics 2014 7 (1): 8. Koestler Devin C, Chalise Prabhakar, Cicek Mine S, Cunningham Julie M, Armasu Sebastian, Larson Melissa C, Chien Jeremy, Block Matthew, Kalli Kimberly R, Sellers Thomas A, Fridley Brooke L, Goode Ellen |
| Characterization of basal-like subtype in a Danish consecutive primary breast cancer cohort. Acta oncologica (Stockholm, Sweden) 2017 11 57 (1): 51-57. Kinalis Savvas, Nielsen Finn Cilius, Talman Maj-Lis, Ejlertsen Bent, Rossing Mar |
| Double heterozygous mutation in the BRCA1 and ATM genes involved in development of primary metachronous tumours: a case report. Breast cancer research and treatment 2019 7 177 (3): 767-770. Andrés Raquel, Menao Sebastian, Arruebo María, Quílez Elisa, Cardiel Maria Jo |
| Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer. PeerJ 2019 11 7 e7976. Wang Yaozong, Song Baorong, Zhu Leilei, Zhang X |
| TP53 Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 7 27 (20): 5566-5575. Bomben Riccardo, Rossi Francesca Maria, Vit Filippo, Bittolo Tamara, D'Agaro Tiziana, Zucchetto Antonella, Tissino Erika, Pozzo Federico, Vendramini Elena, Degan Massimo, Zaina Eva, Cattarossi Ilaria, Varaschin Paola, Nanni Paola, Berton Michele, Braida Alessandra, Polesel Jerry, Cohen Jared A, Santinelli Enrico, Biagi Annalisa, Gentile Massimo, Morabito Fortunato, Fronza Gilberto, Pozzato Gabriele, D'Arena Giovanni, Olivieri Jacopo, Bulian Pietro, Pepper Chris, Hockaday Anna, Schuh Anna, Hillmen Peter, Rossi Davide, Chiarenza Annalisa, Zaja Francesco, Di Raimondo Francesco, Del Poeta Giovanni, Gattei Valt |
| Disparities in Tumor Mutational Burden, Immunotherapy Use, and Outcomes Based on Genomic Ancestry in Non-Small-Cell Lung Cancer. JCO global oncology 2021 11 7 1537-1546. Brawley Otis W, Luhn Patricia, Reese-White Deonna, Ogbu Uzor C, Madhavan Sriraman, Wilson Gerren, Cox Meghan, Ewing Altovise, Hammer Christian, Richie Nico |
| Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting. BMC cancer 2023 4 23 (1): 352. Julian Cristina, Pal Navdeep, Gershon Anda, Evangelista Marie, Purkey Hans, Lambert Peter, Shi Zhen, Zhang Qi |
| Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers. Targeted oncology 2023 11 . Marine Marchal, Vincent Leroy, Hélène Behal, Eric Dansin, Nicolas Paris, Soraya Bordier, Sarah Humez, Fabienne Escande, Clément Gauvain, Alexis B Cort |
| Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy. Cancer medicine 2024 8 13 (15): e7399. Pavel Vodárek, Dominika Écsiová, Vladimíra ?ezá?ová, Ond?ej Sou?ek, Martin Šimkovi?, Doris Vokurková, David Belada, Pavel Žák, Lukáš Smol |
| Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study. EBioMedicine 2024 10 109 105373. Rémy Nicolle, Cindy Canivet, Laurent Palazzo, Bertrand Napoléon, Mira Ayadi, Camille Pignolet, Jérôme Cros, Sophie Gourgou, Janick Selves, Jérôme Torrisani, Nelson Dusetti, Pierre Cordelier, Louis Buscail, Barbara Bournet, |
- Page last reviewed:Feb 1, 2024
- Content source: